Homocysteine-lowering treatment: an overview

Author： Stehouwer Coen DA   Guldener Coen van  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.9, 2001-09, pp. : 1449-1460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homocysteine-lowering therapy improves endothelial function

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Homocysteine-lowering therapy cost effective in CHD?

By  

Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Homocysteine-lowering therapy lowers risk of CHD?

By  

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Homocysteine-lowering therapy cost effective in CHD?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease

By Sunder-Plassmann G.   Winkelmayer W.C.   Födinger M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2637-2652

Informa Healthcare

Access to resources Recommend Favorite